Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011)

I. Mitchell, B. Paes, K. Lanctot, A. Li (Hamilton, Canada)

Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Session: Epidemiology of various respiratory diseases
Session type: Thematic Poster Session
Number: 3978
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Mitchell, B. Paes, K. Lanctot, A. Li (Hamilton, Canada). Risk factors that determine time to first RSV hospitalization in CARESS: The Canadian registry of palivizumab (2005-2011). Eur Respir J 2012; 40: Suppl. 56, 3978

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
RSV hospitalization in Down syndrome in the Canadian Registry of Synagis (CARESS) following prophylaxis (2006-2011)
Source: Annual Congress 2012 - New insights into respiratory infections in children
Year: 2012

CARESS: The Canadian registry of palivizumab (2005-2010)
Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae
Year: 2011


Factors associated with compliance with palivizumab treatment in the Canadian rSV evaluation study for synagis (CARESS) registry (32005-2011)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012

RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012)
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


An assessment of the use of palivizumab over 12 years from a Canadian Registry (CARESS).
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019


Comorbidity and mortality in Swedish asthma patients 2006 – 2013 - An observational register study (PACEHR)
Source: International Congress 2016 – Asthma management in primary care
Year: 2016

Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010-2012)
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013



Changing incidence of pneumonia diagnosis in UK primary care from 2002-2017: Population-based cohort study
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019


Pneumonia incidence trends in a UK general practice population cohort 1991-2003
Source: Annual Congress 2008 - COPD and miscellaneous
Year: 2008


Mortality rates for chronic lower respiratory diseases in Italy from 1979 to 2010: an age–period–cohort analysis
Source: ERJ Open Res 2016
Year: 2016



Influence of comorbidities in the clinical presentation of invasive pneumococcal disease (IPD) in adults in Spain, 2010-2013. The ODIN study
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study
Source: Eur Respir J 2016; 47: 186-193
Year: 2016



Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Factor associated with global mortality in COPD between 2006 and 2011: French claims data
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


Respiratory syncytial virus (RSV) hospitalization in infants with congenital airway anomalies (CAA) in the canadian registry of palivizumab (CARESS) after prophylaxis (2005-2012)
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014

Hospitalisation rates due to respiratory diseases in paediatric patients 1998-2002
Source: Eur Respir J 2004; 24: Suppl. 48, 622s
Year: 2004

Asthma hospitalization rates and asthma mortality in Chilean Children: 2008-2014
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018

Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study
Source: Eur Respir J 2015; 46: 1131-1139
Year: 2015



Time trends in asthma: Changes of prevalence from 1990 to 2010 in Italy. Preliminary results from the screening stage of the Genes Environment Interaction in Respiratory Diseases (GEIRD) study
Source: Annual Congress 2010 - Highlights of longitudinal, geographical and time trend studies of asthma and COPD
Year: 2010